In the News

The debate over whether Americans should receive a booster dose of the Pfizer/BioNTech COVID-19 vaccine moved to a panel of independent expert advisers to the U.S. Food and Drug Administration on Friday.

It's not clear if or when boosters doses of Covid-19 vaccines will be OK'd for fully vaccinated people in the United States, but state and local health departments across the United States are moving ahead with plans for a potential rollout next week.

Doctors like Durbin are stressing the vaccines are safe and many will not need a booster.

As companies continue to ramp up vaccine mandates to combat the contagious delta variant, some institutions are giving employees a chance to opt-out of getting the vaccine if they have a medical exemption.

A week before President Biden’s plan is to roll out, scientists are at odds about whether extra coronavirus shots are needed and for whom.

The delta mutation is causing a surge in COVID-19 cases, here in Idaho and across the country. This is not the first variant to spike infections — and it won’t be the last.

The pace of new infections is falling in some of the states that saw the earliest impact of the delta variant this past summer, while in states like West Virginia and Kentucky, the variant is still taking hold.

This fall’s crowded college and professional football stadiums could create ripe conditions for COVID-19 to spread among unvaccinated fans, experts say.

In his most forceful pandemic actions and words, President Joe Biden on Thursday ordered sweeping new federal vaccine requirements for as many as 100 million Americans — private-sector employees as well as health care workers and federal contractors — in an all-out effort to curb the surging COVID-19 delta variant.

People who were not fully vaccinated this spring and summer were more than 10 times more likely to be hospitalized, and 11 times more likely to die of covid-19, than those who were fully vaccinated, according to one of three major studies published Friday by the Centers for Disease Control and Prevention.

The WHO recently labeled Mu (B.1.621 and first discovered in Colombia) a variant of interest as preliminary data indicated it may better elude immunity from prior infection or vaccination.

Complete protection against infection has long been hailed as the holy grail of vaccination. It might simply be unachievable.